Perspectives on Introduction and Implementation of New Point-of-Care Diagnostic Tests.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. suppl_2, p. S181, doi. 10.1093/infdis/jis203
- By:
- Publication type:
- Article
Works by Metzler, Mutsumi
Results: 7
1
2
The role of economic evaluations in advancing HIV multipurpose prevention technologies in early-stage development.
- Published in:
- Frontiers in Reproductive Health, 2024, p. 1, doi. 10.3389/frph.2024.1272950
- By:
- Publication type:
- Article
3
Willingness to pay for a 4% chlorhexidine (7.1% chlorhexidine digluconate) product for umbilical cord care in rural Bangladesh: a contingency valuation study.
- Published in:
- BMC International Health & Human Rights, 2013, v. 13, n. 1, p. 44, doi. 10.1186/1472-698X-13-44
- By:
- Publication type:
- Article
4
Using Consumer Data to Inform Marketing Strategies for Chlorhexidine for Umbilical Cord Care Programming in Kenya and Nigeria.
- Published in:
- Social Marketing Quarterly, 2018, v. 24, n. 4, p. 235, doi. 10.1177/1524500418797296
- By:
- Publication type:
- Article
5
Cost for sickle cell disease screening using isoelectric focusing with dried blood spot samples and estimation of price thresholds for a point-of-care test in Uganda.
- Published in:
- Journal of Blood Medicine, 2019, v. 10, p. 59, doi. 10.2147/JBM.S186528
- By:
- Publication type:
- Article
6
A Field Evaluation of the Hardy TB MODS Kit™ for the Rapid Phenotypic Diagnosis of Tuberculosis and Multi-Drug Resistant Tuberculosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107258
- By:
- Publication type:
- Article
7
Selecting an appropriate strategy to make quality 7.1% chlorhexidine digluconate accessible for umbilical cord care.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2016, v. 9, p. 1, doi. 10.1186/s40545-016-0063-9
- By:
- Publication type:
- Article